Avanos Medical Inc
AVNS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.16B
Close$
$13.46
46.1% downside
Current Fair Value
46.1% downsideOvervalued by 46.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.16 Billion |
|---|---|
| Enterprise Value | $1.23 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.46 |
| Beta | 1.59 |
| Outstanding Shares | 46,400,000 |
Return
| Return on Equity | -8.87% |
|---|---|
| Return on Assets | -6.61% |
| Return on Invested Capital | -8.07% |
Valuation & Multiples
| P/E Ratio | -16.58 |
|---|---|
| PEG | 72.97 |
| Price to Sales | 1.67 |
| Price to Book Ratio | 1.56 |
| Enterprise Value to Revenue | 1.72 |
| Enterprise Value to EBIT | -16.63 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$170.00 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$173.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 14,500▼ 31.60% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 96.90%▼ 0.91% |
|---|---|
| Total Invested | $630.22M▲ 23.63% |
| Investors Holding | 253▼ 18.00% |
ESG Score
No data
About Avanos Medical Inc
CEO: Joseph Woody